Publication
Article
BioPharm International
BioPharm International-12-16-2013Volume2013 eBook Issue 1
Leveraging Development Strengths Drives Therapies to Market
Author(s):
NPS Pharmaceuticals uses its expertise in development, regulatory compliance, and commercialization to bring to market products with orphan drug status.
Established biopharmaceutical company NPS Pharmaceuticals uses its expertise in development, regulatory compliance, and commercialization to bring to market products with orphan drug status.
Read this article from BioPharm International’s 2013 Innovation Updates and Strategies eBook.
View other articles in the 2013 Innovation Updates and Strategies eBook.
Articles in this issue
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Videos
Related Content
